GlassScriptPhysician profile
Michael L Richter
NPI 1609978329
$2,377.46
in general payments reported to CMS, 2019-2025
15 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $313 · 2021: $161 · 2022: $425 · 2023: $297 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,219.64 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Alkermes, INC. | $370.61 | 2019-2022 | |
| Orexo US, INC. | $176.73 | 2019-2022 | |
| Lilly USA, LLC | $127.55 | 2020-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.18 | 2019 | |
| Pfizer INC. | $94.29 | 2019-2020 | |
| Exact Sciences Corporation | $73.76 | 2023-2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $51.66 | 2019 | |
| Alk-Abello, INC | $45.42 | 2023-2025 | Neffy, Odactra, Ragwitek |
| Sanofi Pasteur INC. | $22.45 | 2023 | |
| Renalytix Ai, INC. | $22.19 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Indivior INC. | $22.17 | 2019 | |
| Abbott Laboratories | $20.00 | 2021 | |
| Hikma Pharmaceuticals USA | $18.63 | 2023 | Kloxxado, Ryaltris |
| Seqirus USA INC | $17.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.